BioLife Solutions BLFS Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioLife Solutions's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioLife Solutions's common stock, shares authorized (in shares)?
- BioLife Solutions (BLFS) reported common stock, shares authorized (in shares) of $150M in Q1 2026.
- How has BioLife Solutions's common stock, shares authorized (in shares) changed year-over-year?
- BioLife Solutions's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $150M to $150M.
- What is the long-term trend for BioLife Solutions's common stock, shares authorized (in shares)?
- Over 3 years (2022 to 2025), BioLife Solutions's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $150M to $150M.